"Designing Growth Strategies is in our DNA"
Gastroparesis is a medical condition that disturbs the natural movement of the muscles of the stomach, leading to the slow or stationary motility of the stomach and preventing it from emptying. Gastroparesis can damage the vagus nerve which regulates the metabolic system and may result in nausea, vomiting and can also affect blood sugar levels. The categories of gastroparesis include diabetic, idiopathic, and post-surgical gastroparesis. Among them, diabetic gastroparesis is considered one of the most common forms. The increased R&D by manufacturers for the treatment of this disease is expected to drive the market.
The increase in incidences and prevalence of diabetes is the primary factor for the growth of this market. World Health Organization estimated that 422 million people were diagnosed with diabetes in 2016 and one of the leading causes of death in the world. Moreover, according to the American Diabetes Association 2019, gastroparesis is a disorder affecting people with both type 1 and type 2 diabetes, and the number of patients with gastroparesis could potentially be parallel to millions. In addition to that, an increase in the geriatric population around the world, sedentary lifestyles have led to an increasing incidence of diabetic cases. Furthermore, continuous efforts by manufacturers for the more advanced drug for the treatment of gastroparesis will also drive the market growth.
However, stringent guidelines for the approval of novel drugs and the lack of awareness about gastroparesis among the populace are likely to restrict the growth of the market.
Key Market Driver -
An increase in incidences and prevalence of diabetes is the primary factor for the growth of this market
Key Market Restraint -
The lack of awareness about gastroparesis among the populace is likely to hinder the market growth
The global diabetic gastroparesis market can be segmented on the basis of types, treatment, end-users, and region. Based on the type, the market can be segmented into, grade 2 (compensated gastroparesis), and grade 3 (gastric failure). Based on the treatment, the market can be segmented into pharmacological treatment and surgery. The pharmacological treatment segment can further be segmented into prokinetics, antiemetic agents, botulinum toxin, and others. Based on the distribution channel, the market can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others.
Geographically, the diabetic gastroparesis market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The major companies in the global diabetic gastroparesis report include Theravance Biopharma., Abbott, Allergan, AstraZeneca, Cadila Pharmaceuticals., Evoke Pharma, Neurogastrx, Inc, Bausch Health. Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and other prominent players.
Geographically, the global diabetic gastroparesis market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia-Pacific region is at the forefront of the current epidemic of diabetes and this region is expected to dominate the global diabetic gastroparesis market and follow the same trend during the forecast period. Moreover, the geriatric population in the Asia Pacific region is quite higher than any other area worldwide and diabetic neuropathy is leading to an increase in incidences of diabetic gastroparesis. North America is projected to hold the second-largest share of the market, followed by Europe. The growth in this region can be attributed to an increase in diabetes patients and high awareness regarding gastroparesis treatment.
To gain extensive insights into the market, Request for Customization
By Distribution Channel
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry